| Supernus Pharms., Inc. v. Appco Pharma LLC, 24-0807 (D. Del.) |
July 1, 2025 |
Hon. Jennifer L. Hall |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,85
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Aurobindo Pharma Ltd., 24-0808 (D. Del.) |
July 1, 2025 |
Hon. Jennifer L. Hall |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Takeda Pharms. U.S.A., Inc. v. Lupin, Ltd., 25-12574 (D.N.J.) |
July 1, 2025 |
Hon. Robert Kirsch |
Eohilia® (budesonide oral suspension) |
11,260,064
11,564,934 |
| Ferring Pharms. Inc. v. Alkem Labs. Ltd., 25-0810 (D. Del.) |
July 2, 2025 |
Hon. Colm F. Connolly |
Clenpiq® (sodium picosulfate / magnesium oxide / anhydrous citric acid oral solution) |
9,827,231
10,624,879
11,191,753 |
| Azurity Pharms., Inc. v. Saba Ilac Sanayi ve Ticaret AS, 25-0814 (D. Del.) |
July 2, 2025 |
Hon. Maryellen Noreika |
Edarbyclor® (azilsartan medoxomil / chlorthalidone tablets) |
9,066,936
9,169,238
9,387,249 |
| Neurelis, Inc. v. Padagis LLC, 25-0821 (D. Del.) |
July 2, 2025 |
Hon. Maryellen Noreika |
Valtoco® (diazepam nasal spray) |
11,241,414
11,793,786
12,268,664 |
| Orion Corp. v. Alembic Pharms Ltd., 25-0825 (D. Del.) |
July 3, 2025 |
Hon. Jennifer L. Hall |
Nubeqa® (darolutamide tablets) |
10.010.530
10.383.853
10.835.515
11.168.058 |
| Mitsubishi Tanabe Pharma Corp. v. Lupin Ltd., 25-0828 (D. Del.) |
July 3, 2025 |
Hon. Jennifer L. Hall |
Radivaca Ors® (edaravone oral suspension) |
12,285,409 |
| Heron Therapeutics, Inc. v. Qilu Pharm. Co., Ltd., 25-0829 (D. Del.) |
July 3, 2025 |
Hon. William C. Bryson |
Cinvanti® (aprepitant injectable emulsion) |
9,561,229
9,808,465
9,974,742
9,974,793
9,974,794
10,500,208
10,624,850
10,953,018
11,173,118
11,744,800
12,115,254
12,115,255
12,290,520 |
| Ascendis Pharma A/S v. Biomarin Pharm. Inc., 25-5696 (N.D. Cal.) |
July 7, 2025 |
Hon. P. Casey Pitts |
Voxzogo® (vosoritide powder for injection) |
RE48,267 |
| Janssen Pharms., Inc. v. Sun Pharm. Indus. Ltd., 25-13061 (D.N.J.) |
July 9, 2025 |
Hon. Claire C. Cecchi |
Invega Sustenna® (palperidone palmitate extended-release injectable suspension) |
9,439,906 |
| Janssen Pharms., Inc. v. Sun Pharm. Indus. Ltd., 25-0857 (D. Del.) |
July 10, 2025 |
Hon. William C. Bryson |
Invega Sustenna® (palperidone palmitate extended-release injectable suspension) |
9,439,906 |
| Hope Medical Enterprises, Inc. v. Accord Healthcare, Inc., 25-0860 (D. Del.) |
July 10, 2025 |
Hon. John F. Murphy |
Sodium Thiosulfate Injection |
12,304,813 |
| Endo Operations Ltd. v. Baxter Healthcare Corp., 25-0861 (D. Del.) |
July 10, 2025 |
Hon. Jennifer L. Hall |
Adrenalin® (epinephrine in 0.9% sodium chloride injection) |
11,071,719
11,207,280
12,133,837
10,653,646
11,083,698 |
| Boehringer Ingelheim Pharms. Inc. v. USV Private Ltd., 25-0862 (D. Del.) |
July 10, 2025 |
Hon. Colm F. Connolly |
Jardiance® (empagliflozin tablets) |
8,551,957
11,090,323
12,115,179 |
| Braintree Labs., Inc. v. Lupin Ltd., 25-13133 (D.N.J.) |
July 10, 2025 |
Hon. Edward S. Kiel |
Suflave® (polyethylene glycol /sodium sulfate / potassium chloride / magnesium sulfate / sodium chloride solution) |
12,239,659
12,290,529 |
| Novartis Pharms. Corp. v. Taro Pharms. USA, Inc., 25-13193 (D.N.J.) |
July 11, 2025 |
Hon. Georgette Castner |
Promacta® (eltrombopag olamine tablets) |
8,052,993
8,052,994
8,062,665
8,071,129
8,828,430 |
| Supernus Pharms., Inc. v. Creekwood Pharms., LLC, 25-13201 (D. Del.) |
July 11, 2025 |
Hon. Michael E. Farbiarz |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. MSN Pharms. Inc., 25-13204 (D. Del.) |
July 11, 2025 |
Hon. Michael E. Farbiarz |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Zenara Pharma Private Ltd., 25-13207 (D. Del.) |
July 11, 2025 |
Hon. Michael E. Farbiarz |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Incyte Corp. v. Sun Pharm. Indus., Inc., 25-13225 (D.N.J.) |
July 11, 2025 |
Hon. Christine P. O’Hearn |
Jakafi® (ruxolitinib tablets) |
8,722,693
8,822,481
8,829,013
10,016,429 |
| Incyte Corp. v. Granules India Ltd., 25-13227 (D.N.J.) |
July 11, 2025 |
Hon. Christine P. O’Hearn |
Jakafi® (ruxolitinib tablets) |
7,598,257
8,415,362
8,722,693
8,822,481
8,829,013 |
| Supernus Pharms., Inc. v. MSN Pharms. Inc., 25-0879 (D. Del.) |
July 15, 2025 |
Hon. Jennifer L. Hall |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Supernus Pharms., Inc. v. Creekwood Pharms., LLC, 25-0880 (D. Del.) |
July 15, 2025 |
Hon. Jennifer L. Hall |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Braintree Labs., Inc. v. Hetero USA, Inc., 25-13632 (D.N.J.) |
July 22, 2025 |
Hon. Christine P. O’Hearn |
Sutab® (sodium sulfate / magnesium sulfate / potassium chloride osmotic laxative tablet) |
10,143,656
11,033,498
11,382,864
11,638,697 |
| Ipsen Biopharmaceuticals, Inc. v. Conjupro Biotherapeutics, Inc., 25-13647 (D.N.J.) |
July 22, 2025 |
Hon. Renee Marie Bumb |
Onivyde® (irinotecan liposome injection) |
12,364,691 |
| Celgene Corp. v. Deva Holding A.S., 25-13687 (D.N.J.) |
July 23, 2025 |
Hon. Esther Salas |
Pomalyst® (pomalidomide capsules) |
8,828,427
9,993,467
10,555,939 |
| Hikma Pharms. USA Inc. v. InfoRLife SA, 25-13688 (D.N.J.) |
July 23, 2025 |
Hon. Robert Kirsch |
Immphentiv® (phenylephrine HCl injection) |
11,471,400
12,257,342 |
| BioDelivery Sciences Int’l, Inc. v. Alvogen PB Research & Development LLC, 25-0926 (D. Del.) |
July 24, 2025 |
Hon. Colm F. Connolly |
Belbuca® (buprenorphine buccal film) |
8,147,866
9,901,539 |
| Novartis Pharms. Corp. v. Teva Pharms., Inc., 25-0928 (D. Del.) |
July 24, 2025 |
Hon. Gregory B. Williams |
Mekinist® (trametinib dimethyl sulfoxide tablets) |
8,580,304
9,155,706
9,271,941
9,399,021 |
| Mitsubishi Tanabe Pharma Corp. v. Cipla USA, Inc., 25-0929 (D. Del.) |
July 24, 2025 |
Hon. Jennifer L. Hall |
Radivaca Ors® (edaravone oral suspension) |
12,285,409 |
| Azurity Pharms., Inc. v. MSN Pharms. Inc., 25-13775 (D.N.J.) |
July 25, 2025 |
Hon. Sisan D. Wigenton |
Fleqsuvy® (baclofen oral suspension) |
11,324,696
11,446,246 |
| Astellas Pharma Inc. v. Lupin Ltd., 25-13779 (D.N.J.) |
July 25, 2025 |
Hon. Michael A. Shipp |
Xtandi® (enzalutamide tablets) |
11,839,689
12,161,628 |
| Gilead Sciences, Inc. v. Aspiro Pharma Ltd., 25-13936 (D.N.J.) |
July 30, 2025 |
Hon. Stanley R. Chesler |
Veklury® (remdesivir injection) |
10,675,296
11,266,681
11,975,017
11,491,169
11,903,953
11,975,012 |
| Sumitomo Pharma Switzerland GmbH v. Sandoz Inc., 25-0970 (D. Del.) |
Aug. 1, 2025 |
Hon. Maryellen Noreika |
Orgovyx® (relugolix tablets) |
11,795,178
12,325,714
12,097,198
12,144,809
12,336,990 |
| BPI Labs, LLC v. Eli Lilly and Co., IPR2025-01346 (PTAB) |
Aug. 4, 2025 |
N/A |
Mounjaro® (tirzepatide injection) Zepbound® (tirzepatide injection) |
9,474,780 |
| Array BioPharma Inc. v. Alembic Pharms. Ltd., 25-1016 (D. Del.) |
Aug. 13, 2025 |
Hon. Colm F. Connolly |
Vitrakvi® (larotrectinib sulfate capsules) |
9,782,414
10,172,861
10,285,993
10,799,505
10,813,936 |
| Bow River LLC v. Alembic Pharms. Ltd., 25-1016 (D. Del.) |
Aug. 13, 2025 |
Hon. Colm F. Connolly |
Vitrakvi® (larotrectinib sulfate capsules) |
11,337,967
11,974,998 |
| Jazz Pharms. Ireland Ltd. v. Granules India Ltd., 25-14606 (D.N.J.) |
Aug. 13, 2025 |
Hon. Stanley R. Chesler |
Xywav® (calcium, magnesium, potassium, and sodium oxybates oral solution) |
8,591,922
8,772,306
8,901,173
9,050,302
9,132,107
9,486,426
10,195,168
10,213,400
10,675,258
10,864,181
11,253,494
11,426,373
11,554,102
11,986,446 |
| American Regent, Inc. v. Hikma Pharms. USA Inc., 25-14671 (D.N.J.) |
Aug. 15, 2025 |
Hon. Brian R. Martinotti |
Multrys® (trace elements zinc / copper / manganese / selenium injection) |
11,786,548
11,975,022
11,998,565
12,150,956
12,150,957 |
| Alkermes, Inc. v. Teva Pharms., Inc., 25-14685 (D.N.J.) |
Aug. 15, 2025 |
Hon. Karen M. Williams |
Lybalvi® (olanzapine / samidorphan tablets) |
11,707,466
11,951,111 |
| Axsome Malta Ltd. v. Alkem Labs. Ltd., 25-14694 (D.N.J.) |
Aug. 15, 2025 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
12,102,609
12,194,016
12,263,145
12,318,362 |
| Bayer Pharma AG v. Dr. Reddy’s Labs., Inc., 25-1043 (D. Del.) |
Aug. 19, 2025 |
Hon. Richard G. Andrews |
Xarelto® (rivaroxaban tablets) |
10,828,310 |
| Vifor (Int’l) AG v. Orbicular Pharm. Techs. Pvt. Ltd., 25-1051 (D. Del.) |
Aug. 21, 2025 |
Hon. William C. Bryson |
Injectafer® (ferric carboxymaltose injection) |
7,612,109
7,754,702
8,895,612
11,364,260
11,433,091
11,478,502 |
| Nexus Pharms., LLC v. Saba Ilac Sanayi ve Ticaret A.S., 25-14927 (D.N.J.) |
Aug. 26, 2025 |
Hon. Claire C. Cecchi |
Emerphed® (ephedrine sulfate injection) |
11,090,278
11,241,400
11,478,436
11,426,369 |
| Alkermes, Inc. v. Apotex Corp., 25-14977 (D.N.J.) |
Aug. 27, 2025 |
Hon. Karen M. Williams |
Lybalvi® (olanzapine / samidorphan tablets) |
11,707,466
11,951,111
12,390,474 |
| Alkermes, Inc. v. Apotex Corp., 25-1086 (D. Del.) |
Aug. 28, 2025 |
Hon. Colm F. Connolly |
Lybalvi® (olanzapine / samidorphan tablets) |
11,707,466
11,951,111
12,390,474 |
| Actelion Pharms. Ltd. v. Seasons Biotechnology (Taizhou) Co. Ltd., 25-15027 (D.N.J.) |
Aug. 28, 2025 |
Hon. Stanley R. Chesler |
Opsumit® (macitentan tablets) |
7,094,781
10,946,015 |
| PH Health Ltd. v. Fresenius Kabi USA, LLC, 25-1096 (D. Del.) |
Aug. 29, 2025 |
Hon. Jennifer L. Hall |
Ephedrine Sulfate Injection |
10,869,845 |
| Baxter Healthcare Corp. v. PH Health Ltd., 25-15120 (D.N.J.) |
Aug. 29, 2025 |
Hon. Madeline Cox Arleo |
Nexterone® (amiodarone HCl premixed injection) |
7,635,773 |
| ARS Pharms. Operations, Inc. v. Lupin Inc., 25-15123 (D.N.J.) |
Aug. 29, 2025 |
Hon. Julien Xavier Neals |
neffy® (epinephrine nasal spray) |
10,576,156
10,682,414
11,173,209
11,191,838
11,717,571
11,744,895
11,918,655
12,324,838 |
| Bausch & Lomb Inc. v. Saba Ilac Sanayi ve Ticaret A.S., 25-15127 (D.N.J.) |
Aug. 29, 2025 |
Hon. Stanley R. Chesler |
Vyzulta® (latanoprostene bunod ophthalmic solution) |
8,058,467 |
| Actelion Pharms. US, Inc. v. VGYAAN Pharms. LLC, 25-15227 (D.N.J.) |
Sept. 3, 2025 |
Hon. Renee Marie Bumb |
Uptravi® (selexipag tablets) |
7,205,302 |
| Onyx Therapeutics, Inc. v. Amneal Pharms. of NY, LLC, 25-1107 (D. Del.) |
Sept. 4, 2025 |
Hon. Gregory B. Williams |
Kyprolis® (carfilzomib injection) |
7,737,112 |
| Jazz Pharms. Ireland Ltd. v. InvaGen Pharms., Inc., 25-15276 (D.N.J.) |
Sept. 4, 2025 |
Hon. Robert Kirsch |
Zepzelca® (lurbinectedin injection) |
12,324,806 |
| Alkermes, Inc. v. MSN Pharms., Inc., 25-15324 (D.N.J.) |
Sept. 5, 2025 |
Hon. Karen M. Williams |
Lybalvi® (olanzapine / samidorphan tablets) |
11,707,466
11,951,111
8,778,960
12,390,474 |
| Supernus Pharms., Inc. v. Macleods Pharms. Ltd., 25-15399 (D.N.J.) |
Sept. 9, 2025 |
Hon. Michael E. Farbiarz |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Astellas Pharma Inc. v. Hetero USA, Inc., 25-15434 (D.N.J.) |
Sept. 10, 2025 |
Hon. Michael A. Shipp |
Xtandi® (enzalutamide tablets) |
11,839,689
12,161,628 |
| Azurity Pharms., Inc. v. Annora Pharma Private Ltd., 25-1139 (D. Del.) |
Sept. 12, 2025 |
Hon. Colm F. Connolly |
Katerzia® (amlodipine benzoate oral suspension) |
10,799,453
11,471,409
11,484,498
11,701,326
11,918,685
12,053,461
12,336,984 |
| Apotex Inc. v. Ipsen Biopharm Ltd., IPR2025-01531 (P.T.A.B.) |
Sept. 12, 2025 |
N/A |
Onivyde® (irinotecan HCl for injection) |
11,344,552 |
| Supernus Pharms., Inc. v. Macleods Pharms. Ltd., 25-1146 (D. Del.) |
Sept. 15, 2025 |
Hon. Jennifer L. Hall |
Qelbree® (viloxazine extended-release capsules) |
9,358,204
9,603,853
9,662,338
11,324,753
11,458,143
12,121,523 |
| Teva Pharms. Int’l GmbH v. Almaject, Inc., 25-1168 (D. Del.) |
Sept. 18, 2025 |
Hon. Jennifer L. Hall |
Bendeka® (bendamustine HCl injection) |
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
10,010,533
10,052,385
11,844,783
11,872,214
12,138,248
12,350,257
12,343,333 |
| GlaxoSmithKline LLC v. Sun Pharm. Indus. Ltd., 25-1170 (D. Del.) |
Sept. 18, 2025 |
Hon. Colm F. Connolly |
Zejula® (niraparib tablets) |
8,071,623
11,091,459
11,673,877 |
| Kudos Pharms. Ltd. v. Sun Pharm. Indus. Ltd., 25-15825 (D.N.J.) |
Sept. 19, 2015 |
Hon. Robert Kirsch |
Zejula® (niraparib tablets) |
8,859,562 |
| Glaxo Group Ltd. v. Transpire Bio Inc., 25-61939 (S.D. Fla.) |
Sept. 25, 2025 |
Hon. Melissa Damian |
Breo Ellipta (fluticasone furoate / vilanterol trifenatate inhaler) |
11,116,721
8,534,281
8,746,242
8,161,968 |
| Axsome Therapeutics, Inc. v. Apotex Inc., 25-16038 (D.N.J.) |
Sept. 26, 2025 |
Hon. Michael E. Farbiarz |
Symbravo® (meloxicam / rizatriptan tablets) |
9,821,075
10,029,010
10,058,614
10,137,131
10,195,278
10,265,324
10,363,31
10,369,224
10,426,839
10,463,736
10,471,014
10,471,069
10,512,692
10,512,693
10,517,950
10,532,101
10,537,642
10,561,664
10,583,144
10,653,777
10,688,102
10,688,185
10,695,429
10,695,430
10,702,535
10,702,602
10,722,583
10,729,696
10,729,697
10,729,773 |
| Orion Corp. v. MSN Pharms. Inc., 25-1201 (D. Del.) |
Sept. 26, 2025 |
Hon. Jennifer L. Hall |
Nubeqa® (darolutamide tablets) |
10,010,530
10,383,853
10,835,515
11,168,058 |
| Pfizer Inc. v. Prinston Pharm. Inc., 25-1202 (D. Del.) |
Sept. 26, 2025 |
Hon. Colm F. Connolly |
Xeljanz® (tofacitinib tablets) |
RE41,783 |
| Boehringer Ingelheim Pharms. Inc. v. Ipca Labs. Ltd., 25-1207 (D. Del.) |
Sept. 29, 2025 |
Hon. Colm F. Connolly |
Jardiance® (empagliflozin tablets) |
11,090,323
11,833,166 |
